NMS · Medical - Care Facilities

The Pennant Group, Inc. (PNTG) Stock

$40.09 -0.68% NMS: PNTG Healthcare

Valuation

MetricValue
Price$40.09
Market Cap$1.39B
P/E Ratio41.74
P/B Ratio3.81
P/S Ratio1.24
EPS (TTM)$0.84
52-Week High$42.74
52-Week Low$22.25
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE9.51%
ROA3.12%
ROCE7.18%
Gross Margin5.49%
Operating Margin5.38%
Net Margin2.93%
Debt/Equity1.38
Current Ratio1.14

Annual Financials (USD)

Metric20212022202320242025
Revenue$440.0M$473.0M$545.0M$695.0M$948.0M
Operating Profit$5.0M$13.0M$25.0M$38.0M$51.0M
Net Profit$3.0M$7.0M$13.0M$23.0M$30.0M
EPS$0.07$0.22$0.44$0.71$0.84
Op Margin1.1%2.7%4.6%5.5%5.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$530.0M$512.0M$540.0M$680.0M$968.0M
Total Liabilities$416.0M$386.0M$394.0M$368.0M$594.0M
Cash$5.0M$2.0M$6.0M$24.0M$17.0M
Borrowings$355.0M$327.0M$330.0M$273.0M$453.0M

Latest News

3 Reasons to Sell PNTG and 1 Stock to Buy Instead StockStory · Jul 17, 2026 What This Pennant Group Insider Sale Means as Home Health Revenue Surged 43% Motley Fool · Jul 14, 2026 Truist Raises Price Target on Pennant Group to $48 From $42, Keeps Buy Rating MT Newswires · Jul 14, 2026 Jim Cramer Outlines Why Pennant Group Stock Can Sail to $55 Insider Monkey · Jul 13, 2026 1 Momentum Stock with Competitive Advantages and 2 We Turn Down StockStory · Jul 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-18.0M$9.0M$33.0M$39.0M$48.0M
Investing Cash Flow$-26.0M$-38.0M$-38.0M$-80.0M$-250.0M
Financing Cash Flow$-1.0M$0$0$-4.0M$-2.0M
Net Cash Flow$5.0M$-3.0M$4.0M$18.0M$-7.0M
Free Cash Flow$-25.0M$-5.0M$25.0M$30.0M$26.0M

Valuation & Return Ratios

MetricValue
PEG Ratio2.60
EV / EBITDA28.22
FCF Yield1.90%
Quick Ratio1.20
Interest Coverage13.97
Return 1Y71.23%
Return 3Y256.08%
Return 5Y11.78%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADUSAddus HomeCare Corporation $114.45 +0.17% 19.59 $2.14B 0.00%
AVAHAveanna Healthcare Holdings Inc. $12.29 +0.37% 9.32 $2.68B 0.00%
BKDBrookdale Senior Living Inc. $9.94 -8.77% -18.60 $2.37B 0.00%
CHEChemed Corp $496.54 -0.34% 25.48 $6.49B 0.55%
EHCEncompass Health Corporation $121.85 -0.56% 19.26 $12.09B 0.70%

About The Pennant Group, Inc.

The Pennant Group, Inc. is led by CEO Brent J. Guerisoli, employs 7,000 people, headquartered in US, publicly traded since 2019.

The Pennant Group, Inc. (PNTG) stock trades at $40.09 with a market capitalization of $1.39B. The stock is valued at a price-to-earnings (P/E) ratio of 41.74, price-to-book of 3.81, price-to-sales of 1.24. Over the past 52 weeks the stock has ranged between $22.25 and $42.74, and currently trades 6.2% below its 52-week high.

On profitability, The Pennant Group, Inc. generates a return on equity (ROE) of 9.51%, return on capital employed of 7.18%, an operating margin of 5.38%, a net profit margin of 2.93%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1174.49 +0.42% JNJ Johnson & Johnson $261.01 +1.76% ABBV AbbVie Inc. $277.37 +1.82% MRK Merck & Company, Inc. Common Stock (new) $145.82 +2.42% UNH UnitedHealth Group Incorporated Common Stock (DE) $378.12 +1.93% NVS Novartis AG $143.26 +0.10% AZN AstraZeneca PLC $159.37 +0.37% TMO Thermo Fisher Scientific Inc $659.71 +1.19% AMGN Amgen Inc. $415.88 +2.07% GILD Gilead Sciences, Inc. $151.29 +2.85% ABT Abbott Laboratories $99.18 +0.70% NVO Novo Nordisk A/S $38.39 +0.54%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides